PDL BioPharma, Inc. EBT margin

EBT margin of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBT margin growth rates and interactive chart. The Earnings before tax margin. Calculated as earnings before tax divided by revenue. Measures the profitability of a company after all expenses are paid but before taxes. This is useful to compare various companies in an industry that might have different tax regimes or tax rates.


Highlights and Quick Summary

  • EBT margin for the quarter ending June 29, 2020 was -268.78% (a -65.15% decrease compared to previous quarter)
  • Year-over-year quarterly EBT margin increased by 496.23%
  • Annual EBT margin for 2019 was -134.67% (a 377.05% increase from previous year)
  • Annual EBT margin for 2018 was -28.23% (a -148.97% decrease from previous year)
  • Annual EBT margin for 2017 was 57.65% (a 28.77% increase from previous year)
  • Twelve month EBT margin ending June 29, 2020 was -220.22% (a 7.56% increase compared to previous quarter)
  • Twelve month trailing EBT margin increased by 3046.0% year-over-year
Trailing EBT margin for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-220.22% -204.75% -134.67% -7.0%
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBT margin of PDL BioPharma, Inc.

Most recent EBT marginof PDLI including historical data for past 10 years.

Interactive Chart of EBT margin of PDL BioPharma, Inc.

PDL BioPharma, Inc. EBT margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -268.78% -771.31%
2019 952.81% -45.08% -142.01% -138.89% -134.67%
2018 72.17% 52.22% -271.74% 6.8% -28.23%
2017 45.54% 40.62% 79.47% 30.25% 57.65%
2016 -21.93% 52.77% 32.33% 86.15% 44.77%
2015 91.38% 88.55% 89.49% 89.19% 89.79%
2014 76.89% 90.89% 89.74% 84.5% 86.24%
2013 84.21% 86.03% 91.4% 89.82% 88.08%
2012 83.43% 87.92% 90.0% 79.89% 85.89%
2011 82.35% 84.68% 88.4% 82.29% 84.92%
2010 -48.31% 73.13% 69.57% 43.59%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.